Premature rupture of membranes: current concepts in diagnosis, management and prevention
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20263481Keywords:
Preterm premature rupture of membranes, Diagnosis, Management, Corticosteroids, Antibiotic therapyAbstract
Premature rupture of membranes (PROM) is an obstetric complication associated with adverse maternal and neonatal outcomes. Preterm PROM (PPROM) contributes substantially to preterm birth and unfavorable perinatal outcomes. This narrative review summarizes current evidence regarding the risk factors, diagnosis, management, and prevention of PROM and PPROM. A literature search was conducted using PubMed, Scopus, and Google Scholar for relevant publications from 2000 to 2026. Relevant clinical trials, systematic reviews, and clinical guidelines were included. Diagnosis of PROM requires clinical evaluation with the help of biochemical markers such as placental alpha microglobulin-1 (PAMG-1) and insulin-like growth factor binding protein-1 (IGFBP-1). The management strategies are based on gestational age and include antibiotic therapy, antenatal corticosteroids, magnesium sulfate for fetal neuroprotection, and careful assessment of maternal and fetal well-being. Early recognition, accurate diagnosis, and evidence-based management are essential for improving maternal and neonatal outcomes associated with PROM and PPROM. Management should be individualized according to gestational age and maternal and fetal clinical status, with appropriate use of antibiotics, antenatal corticosteroids, magnesium sulfate for fetal neuroprotection, and close monitoring when indicated. Preventive strategies addressing modifiable risk factors may further contribute to reducing the burden of PROM and PPROM.
Metrics
References
Prelabor Rupture of Membranes: ACOG Practice Bulletin, Number 217. Obstet Gynecol. 2020;135(3):e80-97. DOI: https://doi.org/10.1097/AOG.0000000000003700
Tiruye G, Shiferaw K, Tura AK, Debella A, Musa A. Prevalence of premature rupture of membrane and its associated factors among pregnant women in Ethiopia: A systematic review and meta-analysis. SAGE Open Med. 2021;9:20503121211053912. DOI: https://doi.org/10.1177/20503121211053912
Idrisa A, Pius S, Bukar M. Maternal and neonatal outcomes in premature rupture of membranes at University of Maiduguri Teaching Hospital, Maiduguri, North-Eastern Nigeria. Trop J Obstet Gynaecol. 2019;36(1):15. DOI: https://doi.org/10.4103/TJOG.TJOG_89_18
Addisu D, Melkie A, Biru S. Prevalence of Preterm Premature Rupture of Membrane and Its Associated Factors among Pregnant Women Admitted in Debre Tabor General Hospital, North West Ethiopia: Institutional-Based Cross-Sectional Study. Obstet Gynecol Int. 2020;2020:4034680. DOI: https://doi.org/10.1155/2020/4034680
Dars S, Malik S, Samreen I, Kazi RA. Maternal morbidity and perinatal outcome in preterm premature rupture of membranes before 37 weeks gestation. Pak J Med Sci. 2014;30(3):626-9. DOI: https://doi.org/10.12669/pjms.303.4853
Mercer BM. Preterm premature rupture of the membranes. Obstet Gynecol. 2003;101(1):178-93. DOI: https://doi.org/10.1016/S0029-7844(02)02366-9
Sharma M, Agrwal M, Goudappagoudra H. Maternal and fetal outcome in preterm premature rupture of membrane. Int J Reproduct Contracept Obstet Gynecol. 2021;10(11):4178-82. DOI: https://doi.org/10.18203/2320-1770.ijrcog20214328
Garg A, Jaiswal A. Evaluation and Management of Premature Rupture of Membranes: A Review Article. Cureus. 2023;15(3):e36615. DOI: https://doi.org/10.7759/cureus.36615
Choudhary M, Rathore SB, Chowdhary J, Garg S. Pre and post conception risk factors in PROM. Int J Res Med Sci. 2015;3(10):2594-8. DOI: https://doi.org/10.18203/2320-6012.ijrms20150797
Caughey AB, Robinson JN, Norwitz ER. Contemporary diagnosis and management of preterm premature rupture of membranes. Rev Obstet Gynecol. 2008;1(1):11-22.
Seaward PG, Hannah ME, Myhr TL, Farine D, Ohlsson A, Wang EE, et al. International Multicentre Term Prelabor Rupture of Membranes Study: evaluation of predictors of clinical chorioamnionitis and postpartum fever in patients with prelabor rupture of membranes at term. Am J Obstet Gynecol. 1997;177(5):1024-9. DOI: https://doi.org/10.1016/S0002-9378(97)70007-3
Ghafoor S. Current and Emerging Strategies for Prediction and Diagnosis of Prelabour Rupture of the Membranes: A Narrative Review. Malays J Med Sci. 2021;28(3):5-17. DOI: https://doi.org/10.21315/mjms2021.28.3.2
Abdelazim IA, Makhlouf HH. Placental alpha microglobulin-1 (AmniSure(®) test) for detection of premature rupture of fetal membranes. Arch Gynecol Obstet. 2012;285(4):985-9. DOI: https://doi.org/10.1007/s00404-011-2106-4
Tchirikov M, Schlabritz-Loutsevitch N, Maher J, Buchmann J, Naberezhnev Y, Winarno AS, et al. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. J Perinat Med. 2018;46(5):465-88. DOI: https://doi.org/10.1515/jpm-2017-0027
Palacio M, Kühnert M, Berger R, Larios CL, Marcellin L. Meta-analysis of studies on biochemical marker tests for the diagnosis of premature rupture of membranes: comparison of performance indexes. BMC Pregnancy Childbirth. 2014;14:183. DOI: https://doi.org/10.1186/1471-2393-14-183
Elçi E, Güneş Elçi G, Sayan S. Comparison of the accuracy and reliability of the AmniSure, AMNIOQUICK, and AL-SENSE tests for early diagnosis of premature rupture of membranes. Int J Gynaecol Obstet. 2020;149(1):93-7. DOI: https://doi.org/10.1002/ijgo.13097
Pourali L, Saghafi N, Eslami Hasan Abadi S, Tara F, Vatanchi AM, Motamedi E. Induction of labour in term premature rupture of membranes; oxytocin versus sublingual misoprostol; a randomised clinical trial. J Obstet Gynaecol. 2018;38(2):167-71. DOI: https://doi.org/10.1080/01443615.2017.1329284
Kenyon S, Boulvain M, Neilson JP. Antibiotics for preterm rupture of membranes. Cochrane Database Syst Rev. 2010;(8):CD001058. DOI: https://doi.org/10.1002/14651858.CD001058.pub2
Chatzakis C, Papatheodorou S, Sarafidis K, Dinas K, Makrydimas G, Sotiriadis A. Effect on perinatal outcome of prophylactic antibiotics in preterm prelabor rupture of membranes: network meta-analysis of randomized controlled trials. Ultrasound Obstet Gynecol. 2020;55(1):20-31. DOI: https://doi.org/10.1002/uog.21884
Kenyon SL, Taylor DJ, Tarnow-Mordi W, ORACLE Collaborative Group. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial. ORACLE Collaborative Group. Lancet. 2001;357(9261):979-88. DOI: https://doi.org/10.1016/S0140-6736(00)04233-1
Mercer BM, Miodovnik M, Thurnau GR, Goldenberg RL, Das AF, Ramsey RD, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. A randomized controlled trial. National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. JAMA. 1997;278(12):989-95. DOI: https://doi.org/10.1001/jama.1997.03550120049032
Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3(3):CD004454. DOI: https://doi.org/10.1002/14651858.CD004454.pub3
Gyamfi-Bannerman C, Thom EA, Blackwell SC, Tita ATN, Reddy UM, Saade GR, et al. Antenatal Betamethasone for Women at Risk for Late Preterm Delivery. N Engl J Med. 2016;374(14):1311-20. DOI: https://doi.org/10.1056/NEJMoa1516783
Medina TM, Hill DA. Preterm premature rupture of membranes: diagnosis and management. Am Fam Physician. 2006;73(4):659-64.
Vidaeff AC, Doyle NM, Gilstrap LC. Antenatal corticosteroids for fetal maturation in women at risk for preterm delivery. Clin Perinatol. 2003;30(4):825-40. DOI: https://doi.org/10.1016/S0095-5108(03)00102-7
Ubom AE, Vatish M, Barnea ER, FIGO Childbirth and Postpartum Hemorrhage Committee. FIGO good practice recommendations for preterm labor and preterm prelabor rupture of membranes: Prep-for-Labor triage to minimize risks and maximize favorable outcomes. Int J Gynaecol Obstet. 2023;163(2):40-50. DOI: https://doi.org/10.1002/ijgo.15113
Berkman ND, Thorp JM, Lohr KN, Carey TS, Hartmann KE, Gavin NI, et al. Tocolytic treatment for the management of preterm labor: a review of the evidence. Am J Obstet Gynecol. 2003;188(6):1648–59. DOI: https://doi.org/10.1067/mob.2003.356
Conde-Agudelo A, Romero R. Antenatal magnesium sulfate for the prevention of cerebral palsy in preterm infants less than 34 weeks’ gestation: a systematic review and metaanalysis. Am J Obstet Gynecol. 2009;200(6):595-609. DOI: https://doi.org/10.1016/j.ajog.2009.04.005
Gupta N, Jahan U, Seep S, Singh CP, Shukla S. Role of magnesium sulphate as a neuroprotective agent on neonatal outcome in preterm deliveries. Int J Reproduct Contracept Obstet Gynecol. 2023;12(3):658-64. DOI: https://doi.org/10.18203/2320-1770.ijrcog20230534
Casanueva E, Ripoll C, Tolentino M, Morales RM, Pfeffer F, Vilchis P, et al. Vitamin C supplementation to prevent premature rupture of the chorioamniotic membranes: a randomized trial. Am J Clin Nutr. 2005;81(4):859-63. DOI: https://doi.org/10.1093/ajcn/81.4.859
Nath B, Gaikwad H, Roy H, Paul S, Kanti V. Role of Vitamin C Supplementation in the Prevention of Premature Rupture of Membranes (PROM) and Preterm PROM: A Systematic Review and Meta-Analysis. Cureus. 2024;16(6):e62445. DOI: https://doi.org/10.7759/cureus.62445
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2026 SatishKumar B. Puttegowda, Chandana S. Ramakrishna, Shreyank H. Chandrashekara, Vijayalaxmi G. Sasavihalli, Ravindra B. Nagarajappa

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.